LumiMARK biopsy site markers

https://youtu.be/Eq_7fiT00As

LumiMARK™
Biopsy Site Marker

Three multifaceted nitinol shapes designed for easy identification from any angle1

Request Information

Product Support

Visibility Meets Versatility

What Clinicians are Saying:

“To me, [the LumiMARK™ marker] was extremely bright and noticeable. I don’t think I’ve ever had [a biopsy marker] that visible.”

Kathleen Jeffery, MD

Breast Surgeon, Athens, MD

Interested in Learning More?

Contact us to learn how the LumiMARK™ marker can help benefit your practice.

2364

Additional Resources

Frequently Asked Questions

What are the LumiMARK™ markers composed of?
The LumiMARK™ markers are composed of nitinol with no resorbing carrier. The nitinol (grade S) metal is comprised of nickel, titanium, and other minor constituents.
Do the LumiMARK™ markers contain nickel?
The LumiMARK™ markers do contain nickel. Do not use on patients with known nickel allergies.
Why are the LumiMARK™ markers made of nitinol?
Nitinol is a metal alloy that offers shape memory allowing the distinctive markers to be compressed and take full shape upon deployment.
What size are the LumiMARK™ markers?

The Tulip™ clip is 5mm (.20”) x 5mm (.20”).

The Lotus™ clip is 7mm (.27”) x 4mm (.16”).

The Rose™ clip is 10mm (.39”) x 5mm (.20”).

Can you use the LumiMARK™ markers in lymph nodes?
The LumiMARK™ Biopsy Site Marker is indicated to mark tissue associated with a percutaneous breast biopsy procedure, including axillary lymph nodes, and be permanently visible under ultrasound, X-ray and MRI.
Are the LumiMARK™ markers MR safe?
The applicator with metal cannula is not safe for the MR environment. These markers are MR conditional, meaning a patient can be safely scanned in an MRI system meeting the criteria set in the IFU.

See the LumiMARK™ Marker in Action

https://youtu.be/Eq_7fiT00As

Ease of Deployment During Ultrasound-Guided Biopsies

https://youtu.be/b6gGqiB80WA

Would you like more information about Mammotome® Markers?

Contact Us

1. LumiMARK™ Device Tests: PCR-000340 System Design, PCR-000579 Summative Usability, ES-002647 Claims Assessment
2. LumiMARK Design Plan - ADD-000018, Page 7
3. LumiMARK Device Test - ES-002553 GLP Animal Study
4. HydroMARK™ Plus Device Test - PCR-000299, SDR0098 Vacuum Suction Testing
5. HydroMARK™ Plus Device Test - PCR-000414, Summative Usability
6. HydroMARK™ Design Plan – ADD-00013 Rev G, Page 15
7. Indication may not be approved or available in your region. Please check with your local Mammotome representative.
8. MammoMARK® Device Test – PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
9. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins.The American Journal of Surgery, 209(6), 950-958
10. Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Nov;181(5):1295-9. doi: 10.2214/ajr.181.5.1811295. PMID: 14573422.

LumiMARK™ marker ultrasound photos courtesy of Dr. David Holznagel, Inland Imaging

Products may not be approved or available in your region. Please check with your local Mammotome representative.